Leon Cooperman's ELV Position Overview
Leon Cooperman (via Cooperman Leon G) currently holds 340.9K shares of Elevance Health, Inc. (ELV) worth $110.15 M, representing 3.44% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Leon Cooperman has maintained a strategic position in ELV, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 107.4K shares.
Analysis based on 13F filings available since 2013 Q2
Leon Cooperman's Elevance Health (ELV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elevance Health (ELV) Trades by Leon Cooperman
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2023 | +60,000 | New Buy | 60,000 | $444.29 |
| Q3 2023 | +58,140 | Add 96.90% | 118,140 | $435.42 |
| Q4 2023 | +11,860 | Add 10.04% | 130,000 | $471.56 |
| Q3 2024 | +41,000 | Add 31.54% | 171,000 | $520.00 |
| Q4 2024 | +107,400 | Add 62.81% | 278,400 | $368.90 |
| Q2 2025 | +2,500 | Add 0.90% | 280,900 | $388.96 |
| Q3 2025 | +60,000 | Add 21.36% | 340,900 | $323.12 |
Leon Cooperman's Elevance Health Investment FAQs
Leon Cooperman first purchased Elevance Health, Inc. (ELV) in Q2 2023, acquiring 60,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Leon Cooperman has held Elevance Health, Inc. (ELV) for 10 quarters since Q2 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Leon Cooperman's largest addition to Elevance Health, Inc. (ELV) was in Q4 2024, adding 278,400 shares worth $102.7 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Leon Cooperman's firm, Cooperman Leon G, owns 340,900 shares of Elevance Health, Inc. (ELV), valued at approximately $110.15 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Elevance Health, Inc. (ELV) represents approximately 3.44% of Leon Cooperman's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Leon Cooperman's peak holding in Elevance Health, Inc. (ELV) was 340,900 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.